Source:http://linkedlifedata.com/resource/pubmed/id/10368637
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2A
|
pubmed:dateCreated |
1999-7-1
|
pubmed:abstractText |
Glioblastoma is the most invasive form of primary brain tumors, and is often refractory to chemotherapy. Herein, we provide evidence that two highly invasive human glioma cell lines U-87 MG and U-373 MG, entered apoptosis after 48 hours following 24 h growth arrest induced by Doxorubicin (10 micrograms/2 x 10(5) cells/ml). Apoptosis depended solely on the level of intracellular drug accumulation, and it was not related to a functional p53 tumor suppressor factor. The multidrug resistance gene 1 (mdr-1) encoded P-glycoprotein (P-gp) was weakly expressed in these cells upon exposure to Doxorubicin, and exerted no influence on the extent of cellular drug efflux. Drug efflux occurred only in U-373 MG glioma cells subsequent to physical damage of the membrane upon exposure to Doxorubicin. Pretreatment of tumor cells with 10 micrograms/ml Doxorubicin precluded tumor formation on the chorioallantoic membrane (CAM) of embryonated hen eggs. Single-dose application of 0.4 microgram Doxorubicin on CAM/U-87 MG and CAM/U-373 MG tumor transplants inhibited tumor invasion in CAM tissue by 40 to 50%. These data suggest that highly invasive glioblastomas can be driven to apoptosis following growth arrest induced by Doxorubicin, providing that intracellular drug accumulation suffices cytotoxic levels.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
941-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10368637-Antibiotics, Antineoplastic,
pubmed-meshheading:10368637-Apoptosis,
pubmed-meshheading:10368637-Doxorubicin,
pubmed-meshheading:10368637-Glioma,
pubmed-meshheading:10368637-Humans,
pubmed-meshheading:10368637-Neoplasm Invasiveness,
pubmed-meshheading:10368637-P-Glycoprotein,
pubmed-meshheading:10368637-Tumor Cells, Cultured
|
pubmed:articleTitle |
Doxorubicin-induced cell death in highly invasive human gliomas.
|
pubmed:affiliation |
Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|